Jason Alger, Chief Financial Officer at Health Catalyst, Inc. (HCAT), sold 2,823 shares at $6.83 ($19K) on 2024-06-12, disclosed to the SEC on 2024-06-14.
Scheduled sale ($19k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HCAT | SELL | 2023-12-07 | $16K | — | Filing → |
| HCAT | SELL | 2023-09-06 | $26K | — | Filing → |
| HCAT | SELL | 2023-06-08 | $28K | — | Filing → |